Cerebral Microbleeds, Cerebrospinal Fluid, and Neuroimaging Markers in Clinical Subtypes of Alzheimer's Disease

Masaki Ikeda1,2,3, Sayaka Kodaira4, Hiroo Kasahara1

  • 1Department of Neurology, Gunma University Graduate School of Medicine, Maebashi, Japan.

Frontiers in Neurology
|April 23, 2021
PubMed

Insights

Lobar cerebral microbleeds (CMBs) in Alzheimer's disease (AD) are linked to neurodegeneration, particularly in logopenic variant PPA (lvPPA). Increased CMBs correlate with higher neurofilament light chain (NFL) levels, suggesting microvascular injury contributes to lvPPA.

Area of Science:

  • Neurology
  • Neuroimaging
  • Biomarker Research

Background:

  • Lobar cerebral microbleeds (CMBs) are associated with cerebral amyloid angiopathy (CAA) in Alzheimer's disease (AD).
  • The specific relationship between lobar CMBs and distinct AD clinical subtypes remains unclear.
  • Understanding these associations is crucial for diagnosing and managing AD variants.

Purpose of the Study:

  • To investigate the association between lobar CMBs and clinicopathological features across different AD subtypes.
  • To explore the correlation of CMBs with cerebrospinal fluid (CSF) biomarkers and cerebral blood flow (CBF).
  • To elucidate the role of CMBs in the neurodegenerative processes underlying specific AD phenotypes.

Main Methods:

  • Recruited patients with early/late-onset amnestic AD, logopenic variant PPA (lvPPA), and posterior cortical atrophy (PCA).
  • Assessed CSF biomarkers (Aβ, tau, NFL, YKL-40), CMBs, CBF (99mTc ECD-SPECT), and amyloid burden (11C PiB-PET).
  • Analyzed correlations between CMB load, biomarker levels, and CBF across AD subtypes.

Main Results:

  • Lobar CMBs in lvPPA predominantly occurred in the left temporal lobe, correlating inversely with CBF in that region.
  • CSF NFL levels were significantly higher in lvPPA and increased with CMB load across all AD patients.
  • CSF Aβ and tau levels decreased with increasing CMB load in AD patients.

Conclusions:

  • Aberrant brain hypoperfusion in lvPPA may stem from neurodegeneration and microcirculatory dysfunction linked to CMBs.
  • Left-sided CMBs and associated cerebrovascular injury might contribute to the lvPPA phenotype.
  • CMBs are associated with distinct biomarker profiles and neuroimaging findings in AD subtypes, particularly lvPPA.